Fastenal Reaches New 52-Week High (FAST)

NEW YORK ( TheStreet) -- Fastenal Company (Nasdaq: FAST) hit a new 52-week high Friday as it is currently trading at $53.11, above its previous 52-week high of $53.01 with 419,367 shares traded as of 11:30 a.m. ET. Average volume has been 2.2 million shares over the past 30 days.

Fastenal has a market cap of $13.83 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 21.4% year to date as of the close of trading on Thursday.

Fastenal Company, together with its subsidiaries, operates as a wholesaler and retailer of industrial and construction supplies in the United States and internationally. The company has a P/E ratio of 43.5, above the average materials & construction industry P/E ratio of 38.7 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Fastenal as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Fastenal Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Dow Tumbles as Trump Calls Off North Korea Summit

Dow Tumbles as Trump Calls Off North Korea Summit

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Celgene Shares Rise on Plans to Increase Stock Buybacks

Celgene Shares Rise on Plans to Increase Stock Buybacks